Ascelia Pharma AB (publ) (ACE.ST)
ACE.ST Stock Price Chart
Explore Ascelia Pharma AB (publ) interactive price chart. Choose custom timeframes to analyze ACE.ST price movements and trends.
ACE.ST Company Profile
Discover essential business fundamentals and corporate details for Ascelia Pharma AB (publ) (ACE.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
13 Mar 2019
Employees
11.00
Website
https://www.ascelia.comCEO
Magnus O. Corfitzen
Description
Ascelia Pharma AB (publ), a biotech company, operates as an oncology-focused orphan drug development company in Sweden. It is developing Mangoral, a novel non-gadolinium contrast agent, which is in Phase 3 for use in MRI-scans of the liver; and Oncoral, a novel oral chemotherapy tablet, which is in Phase 2 for the treatment of gastric cancer. It has a clinical collaboration agreement with Taiho Oncology, Inc. for the development of Oncoral in combination with LONSURF. Ascelia Pharma AB (publ) was founded in 2000 and is headquartered in Malmö, Sweden.
ACE.ST Financial Timeline
Browse a chronological timeline of Ascelia Pharma AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Nov 2025
Earnings released on 21 Aug 2025
Earnings released on 14 May 2025
EPS came in at -kr 0.23 falling short of the estimated -kr 0.20 by -15.00%.
Earnings released on 7 Feb 2025
EPS came in at -kr 0.29 falling short of the estimated -kr 0.20 by -45.00%.
Earnings released on 7 Nov 2024
EPS came in at -kr 0.42 falling short of the estimated -kr 0.20 by -110.00%.
Earnings released on 15 Aug 2024
EPS came in at -kr 0.39 falling short of the estimated -kr 0.28 by -39.29%.
Stock split effective on 15 Aug 2024
Shares were split 289 : 200 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 16 May 2024
EPS came in at -kr 0.50 falling short of the estimated -kr 0.40 by -25.00%.
Earnings released on 9 Feb 2024
EPS came in at -kr 0.31 surpassing the estimated -kr 0.50 by +38.00%.
Earnings released on 8 Nov 2023
EPS came in at -kr 0.63 surpassing the estimated -kr 0.90 by +30.00%.
Earnings released on 18 Aug 2023
EPS came in at -kr 1.19 falling short of the estimated -kr 0.90 by -32.22%.
Earnings released on 11 May 2023
EPS came in at -kr 1.07 .
Earnings released on 10 Feb 2023
EPS came in at -kr 1.59 surpassing the estimated -kr 2.44 by +35.07%, while revenue for the quarter reached kr 92.00K .
Earnings released on 4 Nov 2022
EPS came in at -kr 0.77 .
Earnings released on 18 Aug 2022
EPS came in at -kr 0.68 .
Earnings released on 11 May 2022
EPS came in at -kr 0.58 .
Earnings released on 10 Feb 2022
EPS came in at -kr 0.86 surpassing the estimated -kr 4.74 by +81.78%.
Earnings released on 4 Nov 2021
EPS came in at -kr 0.82 .
Earnings released on 19 Aug 2021
EPS came in at -kr 1.01 .
Earnings released on 12 May 2021
EPS came in at -kr 1.00 .
Earnings released on 16 Feb 2021
EPS came in at -kr 1.25 .
Earnings released on 5 Nov 2020
EPS came in at -kr 0.35 .
ACE.ST Stock Performance
Access detailed ACE.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.